Next Article in Journal
Smoking and Rheumatoid Arthritis
Next Article in Special Issue
Inhalation of Silver Nanomaterials—Seeing the Risks
Previous Article in Journal
Amelioration of Mitochondrial Dysfunction-Induced Insulin Resistance in Differentiated 3T3-L1 Adipocytes via Inhibition of NF-κB Pathways
Previous Article in Special Issue
Right or Left: The Role of Nanoparticles in Pulmonary Diseases
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Lung Injury Induced by TiO2 Nanoparticles Depends on Their Structural Features: Size, Shape, Crystal Phases, and Surface Coating

Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, School of Biological Science and Medical Engineering, Beihang University, Beijing 100191, China
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2014, 15(12), 22258-22278; https://doi.org/10.3390/ijms151222258
Submission received: 20 September 2014 / Revised: 31 October 2014 / Accepted: 24 November 2014 / Published: 3 December 2014
(This article belongs to the Special Issue Nanotoxicology and Lung Diseases)

Abstract

:
With the rapid development of nanotechnology, a variety of engineered nanoparticles (NPs) are being produced. Nanotoxicology has become a hot topic in many fields, as researchers attempt to elucidate the potential adverse health effects of NPs. The biological activity of NPs strongly depends on physicochemical parameters but these are not routinely considered in toxicity screening, such as dose metrics. In this work, nanoscale titanium dioxide (TiO2), one of the most commonly produced and widely used NPs, is put forth as a representative. The correlation between the lung toxicity and pulmonary cell impairment related to TiO2 NPs and its unusual structural features, including size, shape, crystal phases, and surface coating, is reviewed in detail. The reactive oxygen species (ROS) production in pulmonary inflammation in response to the properties of TiO2 NPs is also briefly described. To fully understand the potential biological effects of NPs in toxicity screening, we highly recommend that the size, crystal phase, dispersion and agglomeration status, surface coating, and chemical composition should be most appropriately characterized.

1. Introduction

Owing to the rapid development of nanoscience and nanotechnology, many kinds of engineered nanoparticles (NPs) are needed and produced. It has been reported that there are more than 2800 nanoparticulate-based applications commercially available in various areas, such as electronics, materials, medicine and energy [1]. A new generation of materials, nanomaterials/nanoparticles are widely used in our daily life in water treatment, clothing, food additives, implants, and disease diagnosis, etc. Therefore, new issues are raised by researchers and scientists regarding the potential health effects and environmental impact of NPs [2,3,4,5].
Nanoscale titanium dioxide (TiO2, diameter < 100 nm), one of the most commonly manufactured NPs, is a noncombustible and odorless white powder that is employed as a white pigment in paints and papers, a photocatalyst in solar cells, an optical coating in ceramics, and a corrosion-protective coating in bone implants, etc. It naturally exists in three crystal structures: anatase (tetragonal), rutile (tetragonal), and brookite (orthorhombic). Anatase and rutile TiO2 both have a tetragonal structure, while the TiO6 octahedron of anatase TiO2 is distorted to be larger than that of the rutile phase [6]. Rutile TiO2 is stable at most temperatures, while anatase is not at an equilibrium phase and is kinetically stabilized. At temperatures between 550 and 1000 °C, anatase transforms to the equilibrium rutile phase. Brookite TiO2 is formed with the edge-sharing TiO6 octahedron and has a larger cell volume. This form of TiO2 is not often used in research. TiO2 has a very low dissociation constant in water and aqueous systems, thus, it is insoluble in water and organic solvents, as well as under physiological conditions.
Generally, TiO2 is considered a poorly soluble, low toxicity NP [7,8,9]. However, Ferin et al. observed that ultrafine TiO2 (~20 nm) accessed the pulmonary interstitium. The acute inflammatory response was indicated in this study by polymorphonuclear (PMN) leukocytes among lavaged cells in rat lung after acute instillation and subchronic inhalation [10]. Oesch and Landsiedel [11] reviewed the genotoxicity of nanomaterials, including nanosized TiO2, which varied in the test systems used. Positive and negative results were obtained in the DNA damage and gene/chromosome mutation tests. When different sizes of the same form of TiO2 were tested in the same laboratory, smaller material induced DNA damage and micronuclei formation while large size material did not [11].
Among the several routes of nanosized TiO2 exposure, inhalation is apparently a more general and important route of exposure to NPs than others like injection, ingestion, and dermal penetration. A few epidemiologic studies have surveyed the carcinogenicity of TiO2 in workers employed in TiO2 production factories by considering the pathophysiology, gender, age and exposure pathways, which were reviewed by NIOSH in 2005 [12]. There is little clear evidence of elevated risks of lung cancer mortality or morbidity among workers exposed to TiO2 dust [13,14,15]. In 2006, the International Agency for Research on Cancer (IARC) classified pigment-grade TiO2 as “possibly carcinogenic to human beings (Group 2B)”, based on the carcinogen policy of the Occupational Safety and Health Administration (OSHA), according to sufficient evidence of carcinogenicity in animals and inadequate evidence for human carcinogenicity [16].
The lung is a primary target organ of NPs exposure via inhalation in the occupational setting. The spectrum of the toxic effects of nanoscale TiO2 on pulmonary responses has raised much concern. When searching for “nano TiO2 and pulmonary” in PubMed, there are 531 results, and of those results, over one-half (304 results) has been published in the last 10 years, and approximately 40% (nearly 207 papers) have been published in the last five years. An increased incidence of lung injury and pulmonary inflammation induced by exposure to TiO2 NPs has been reported in the scientific literature. Sub-chronic and chronic (inhalation or intratracheal instillation) studies have revealed that TiO2 NPs are deposited in the lung and translocated to the lymph nodes [5,17,18,19]. The overload of TiO2 NPs in the lung can exceed the ability of the macrophages to phagocytose and, eventually, transfer across the epithelium and migrate to the deeper pulmonary interstitium to induce the pulmonary inflammatory response in a dose-dependent manner. The most commonly reported biomarkers are largely detected by analyzing the bronchoalveolar lavage fluid (BALF) propertied and the pathology of the lung in vivo. An increased number of macrophages and neutrophils, fibroproliferative lesions and epithelial hypertrophy and hyperplasia in lung alveoli have been observed in exposed animals [20,21,22,23,24,25,26]. The clearing of particles from the alveolar region is much slower and may take weeks to years. Rats, mice and hamsters show different lung burden and clearance patterns for TiO2 NPs, and hamsters are better able to clear TiO2 NPs than similarly exposed mice and rats [14,17,18]. The pulmonary toxicity and tissue injury elicited by TiO2 NPs is based on several physical and chemical properties, which have been reported in many studies [27,28,29,30].
Dose is traditionally considered in toxicity screening. Paracelsus noted, “The right dose differentiates a poison and a remedy.” However, the interaction of TiO2 NPs with a biological system is closely correlated with their structural features including size, shape, crystal phase, and surface coating. In this paper, we will concentrate systematically on the influence of physicochemical features of TiO2 NPs on lung toxicity and pulmonary cell impairment. Although many related studies have been published recently, only selected representative works are cited here. The aim is to understand the correlation of the physicochemical properties of TiO2 NPs with their potential hazardous effects on lung tissue and to help improve their application performance.

2. Structural Features of TiO2 Nanoparticles

2.1. Size

Size is a key factor for nanoparticles. Based on an agreement on the size of nanoparticles among the groups of standards (International Organization for Standardization (ISO), American Society for Testing and Materials (ASTM), and Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR)), the scale from 1 to 100 nm defines the size range of a nanoparticle [31]. The properties of particles change as the size approaches nanoscale. The percentage of atoms becomes significant at the surface of NPs, and there are many active sites on the particle surface. Therefore, many researchers in “nanotoxicology” aim to elucidate the interaction of nanoparticles with biological systems and the mechanism(s) by which they act. For an overview, the lung toxicological effect in animal models and cytotoxicity of TiO2 NPs with different structural features were listed in Table 1 and Table 2. In 1992, Ferin et al. [10] first reported that the ultrafine TiO2 particles (~20 nm) were translocated to the lung interstitium to a greater extent and cleared from the lungs more slowly than fine TiO2 particles (~250 nm) in Fischer 344 rats after the intratracheal instillation of 500 μg of TiO2. Based on a predictive mathematical model (ICRP 1994) [32], Obserdorster et al. [5] figured out the fractional deposition of inhaled particles in different regions of the human respiratory tract, including three regions—the extrathoracic (mouth or nose and throat), the trachea-bronchial and the alveolar regions. NPs mainly deposit in the alveolar region, with approximately 50% of the 20-nm particles depositing efficiently in the alveolar region and only ~15% of this particle size depositing in tracheobronchial and nasopharyngeal regions. This model also supports another report that TiO2 particles (~20 nm) highly accessed the lung interstitium of the rat more than fine TiO2 particles (less than 200 nm) at an equal mass dose [20], resulting in the influx of PMNs into the alveolar space and a large acute pulmonary inflammatory reaction in BALF.
Alveolar macrophages (AM), as phagocytic cells, reside on the alveolar epithelium and clear solid particles through phagocytosis. The macrophage ability of AM has been compared in commercial ultrafine and fine TiO2 particles both in vitro and in vivo. Renwick et al. [33] reported that the ultrafine TiO2 (29 nm mean diameter, 50 m2/g surface area) significantly reduced the ability of J774.2 mouse AM to phagocytose 2 μm indicator latex beads more than the fine TiO2 (250 nm mean diameter, 6.6 m2/g surface area). Oberdörster et al. [34] compared the AM-mediated clearance of the same mass of ultrafine TiO2 (20 nm) and fine TiO2 (250 nm) in the rat. They reported that a volumetric loading of 9% with fine TiO2 caused a retention half-time of 117 days, whereas a volumetric loading of 2.6% with ultrafine TiO2 caused a prolongation of the clearance half-time (541 days). Gibbs-Flournoy et al. [35] also detected that 27-nm TiO2 was internalized into human bronchial epithelial (BEAS-2B) cells and proximity to cellular nuclei with time using darkfield and confocal laser scanning microscopy (DF-CLSM). For any given mass of particles, as particle size decreases, the total particle surface area increases dramatically [5]. The larger particle the surface area is, the greater the toxicity that the ultrafine particles will develop [20]. For the 29 and 250 nm TiO2, the specific surface area is 50 and 6.6 m2/g, respectively. After receiving 0.1 mg of nanoscale TiO2 (rutile, 21-nm average particle size; specific surface area of 50 m2/g), the lungs of ICR mice showed significant changes in morphology and histology, including the disruption of alveolar septa and alveolar enlargement (indicating emphysema), type II pneumocyte proliferation, increased alveolar epithelial thickness, and an accumulation of particle-laden AM [36]. On the contrary, after instillation with 1 mg fine TiO2 (250 nm mean diameter, specific surface area of 6.6 m2/g), the mice showed no inflammatory cells or expression of inflammatory cytokines in the lung tissue at 4, 24, or 72 h [37]. Rats treated with ultrafine TiO2 (29 nm), but not fine TiO2 (250 nm), by instillation had an increased percentage of neutrophils, γ-glutamyl transpeptidase concentration (a measure of cell damage), protein concentration (a measure of epithelium permeability), and lactate dehydrogenase (LDH) in BALF [33]. The genotoxicology of nanosized TiO2 particles on human bronchial epithelial cells was investigated in a size-dependent manner. Nanosized TiO2 particles (10 and 20 nm) induced the oxidative DNA damage by the strand breaks and base damage in the absence of light, but larger sized TiO2 (>200 nm) did not induce any DNA damaging events [38].
Table 1. Lung toxicity in animal models induced by different TiO2 particles.
Table 1. Lung toxicity in animal models induced by different TiO2 particles.
Structural FeatureAnimalsDoseExposure RouteToxicity EffectReference
Ultrafine TiO2 (~20 nm), Fine TiO2 particles (~250 nm)Rats23.5 and 22.3 mg/m3Intratracheal instillation for 6 h per day, 5 day per week for 12 weeksUltrafine particles at equivalent masses access the pulmonary interstitium to a larger extent than fine particles; pulmonary clearance of ultrafine particles was slower (t½ = 501 days) than of larger particles (t½ = 174 days); a similar mass deposition of the two particle types in the lower respiratory tract; ultrafine particles elicited a persistently high inflammatory reaction compared to the larger-sized particles; this correlated well with their greater surface area per mass.[10,34]
Ultrafine TiO2 (~20 nm), larger TiO2 particles (less than 200 nm)Rats Intratracheal instillationUltrafine particles highly access the pulmonary interstitium; PMNs influx into the alveolar space; The acute inflammatory reaction including an increased percentage of neutrophils, γ-glutamyl transpeptidase concentration (a measure of cell damage), protein concentration (a measure of epithelium permeability), and lactate dehydrogenase (LDH) in BALF were induced.[20]
Rutile nano-TiO2 (21 nm)Mice0.1, and 0.5 mgIntratracheal instillation for one timePulmonary emphysema, extensive disruption of alveolar septa, type II pneumocyte hyperplasia, epithelial cell apoptosis, and accumulation of particle-laden macrophages were induced.[36]
Fine TiO2 (250 nm mean diameter)Mice Intratracheal instillation for 4, 24, or 72 hInflammatory cells or expression of inflammatory cytokines were not detected in the lung tissue.[37]
Ultrafine TiO2 particles (1.4 μm)Mice, Rats, Hamster10, 50, and 250 mg/m3Inhalation for 6 h per day, 5 day per week for 12 weeksSpecies differences in pulmonary responses: rats developed a more severe and persistent pulmonary inflammatory response than either mice and hamsters; hamsters are better able to clear TiO2 NPs than similarly exposed mice and rats.[17,18]
Anatase TiO2 nanospheres, short belts (1–5 μm), long nanobelts (4–12 μm)Mice0–30 μgPharyngeal aspirationBoth nanospheres and long nanobelts resulted in the lung deposition of 135 μg TiO2. At 112 day after exposure, the lung burden was significantly lower in nanosphere-exposed mice than in nanobelt-exposed mice.[39]
Rutile TiO2 nanorodsWistar Rats1, and 5 mg/kgIntratracheal instillation for 24 hInflammation responses were examined in BALF (significantly increased neutrophilic inflammation) and whole blood (significantly reduced platelets and elevated numbers of monocytes and granulocytes) at doses of 1 or 5 mg/kg.[40]
Nanoscale TiO2 rods (anatase = 200 nm × 35 nm), nanoscale TiO2 dots (anatase = similar to 10 nm)Rats1 and 5 mg/kgIntratracheal instillationProduced transient lung inflammation and cell injury in rats at 24 h post-exposure, which is similar to the pulmonary effects of rutile TiO2 NPs (300 nm).[41]
Anatase/rutile spheres (TiO2-P25), anatase spheres (TiO2-A), anatase nanobelts (TiO2-NBs)Mice and Rats20, 70, and 200 μgIntratracheal instillationTiO2-A, TiO2-P25, and TiO2-NB caused significant neutrophilia in mice at 1 day in three of four labs, and this effect was resolved by day 7; TiO2-P25 and TiO2-A had no significant effect in rats in any of the labs; Only TiO2 nanobelts caused significant neutrophilia in rats at 1 day after intratracheal instillation in two or three of four labs.[42,43]
Base TiO2 particles, TiO2 particles coated with aluminum oxide (0%–6%) and/or silica (0%–11%)Rats2 and 10 mg/kg; 1130–1300 mg/m3 (high dose)Intratracheal inhalation and instillation for 4 weeksSurface-coated TiO2 produced higher pulmonary inflammation (PMNs in BALF) than the uncoated TiO2 at 24 h in SD rats, but this effect was only a short-term, transient lung inflammatory response and was reversible at one week post-exposure; Surface treatments influenced the toxicity of TiO2 particles.[44]
In situ-produced TiO2 (~21 nm), rutile (<5 μm), nanosized rutile/anatase (~30 nm), nanosized anatase (<25 nm), silica-coated nanosized needle-like rutile (~10 × 40 nm)Mice10 mg/m3Inhalation for 2 h, 4 consecutive days, 4 weeksOnly SiO2-coated rutile commercial TiO2 NPs elicited clear-cut pulmonary neutrophilia, increased expression of tumor necrosis factor (TNF)-α and neutrophil-attracting chemokines; The level of lung inflammation could not be explained by the surface area of the particles, their primary or agglomerate particle size, or free radical formation capacity but was rather explained by the surface coating.[45]
Hydrophobic and silanized ultrafine TiO2Rats250 and 500 μgIntratracheal instillationSilanized TiO2 did not show toxicity, but a much lower pulmonary inflammation was induced in comparison to the hydrophilic uncoated TiO2 in rat lung; Surface properties (surface chemistry) appeared to play an important role in ultrafine particle toxicity.[46]
Pristine TiO2 NPs, TiO2 NPs embedded in paintsMice20 μgOropharyngeally aspiration once a week for 5 weeksThe paint containing TiO2 ENPs did not modify macrophage and neutrophil counts, but mildly induced KC and IL-1β; The incorporation of TiO2 NPs in aged paint matrix blocked most of the particle-induced lung and systemic blood toxicity.[47]
Rutile TiO2 NPs coated with alumina (uf-1), rutile TiO2 NPs coated silica/alumina (uf-2), uncoated anatase/rutile TiO2 (uf-3)Rats1 or 5 mg/kgIntratracheal instillationuf-1 and uf-2 produced transient lung inflammation, and uf-3 produced pulmonary inflammation, cytotoxicity and adverse lung effects, and aggregated macrophages in the alveolar regions of the lung; uf-3 particles showed more chemical reactivity than both uf-1 and uf-2 particles.[48]
Surface-coated rutile TiO2 (~20.6 nm) (coating content: silicon, aluminum, zirconium and polyalcohol)Mice18, 54, and 162 μgIntratracheal instillation for one timeNano-TiO2 deposited in the lung; 3000 genes were altered in the pulmonary system; At low doses, surface-coated rutile TiO2 potentially down-regulated several gene expression associated with ion homeostasis and muscle function in the absence of inflammation.[27]
Commercially TiO2 P25 untreated with hydrophilic surface, TiO2 T805 silanized with hydrophobic surfaceRats0.15, 0.3, 0.6 and 1.2 mgInstillation for one timeThere was no inflammation or persistent DNA damage in the lung of rats exposed to two types of commercial TiO2 at low doses administered.[49]
Fine (180 nm) and ultrafine (20–30 nm) TiO2 particles (hydrophilic), surface modified with methylation (hydrophobic)Rats1 and 6 mgIntratracheal instillation for 16 hA lesser inflammatory response (influx of neutrophils, activated PMNs and total cell number) was induced in rats in comparison to the untreated TiO2; the impact of surface methylation on TiO2 toxicity was negligible; surface area rather than hydrophobic surface determined the pulmonary inflammation.[50]
Table 2. Cytotoxicity of TiO2 particles with different structural features.
Table 2. Cytotoxicity of TiO2 particles with different structural features.
Structural FeatureCell LineDose and Exposure TimeCytotoxicity EffectReference
Ultrafine TiO2 (29 nm mean diameter, 50 m2/g surface area), fine TiO2 (250 nm mean diameter, 6.6 m2/g surface area)Macphage cell line (J774.2)125.45 mg/mL for 4, 8, 24, and 48 hUltrafine and fine particles had no significant cytotoxic effects on J774.2 AM ultrafine TiO2 significantly impair the ability of J774.2 mouse AM to phagocytose 2 μm indicator latex beads more than the fine TiO2.[33]
27 nm TiO2 particlesHuman bronchial epithelial cells (BEAS 2B) 27 nm TiO2 was internalized into BEAS-2B cells and proximity to cellular nuclei between 5 min and 2 h.[35]
Nanosized TiO2 particles (10 and 20, 200 nm)BEAS 2B Nanosized TiO2 particles (10 and 20 nm) induced the oxidative DNA damage, lipid peroxidation, and micronuclei formation in the absence of light, but larger sized TiO2 (>200 nm) did not induce any oxidative stress and DNA damaging events; rutile-sized 200 nm particles induced hydrogen peroxide and oxidative DNA damage in the absence of light but the anatase-sized 200 nm particles did not.[38]
Spherical TiO2 NPs (12–140 nm; both anatase and rutile)Human lung carcinoma epithelial cell line (A549 cells) Single strand breaks, oxidative lesions to DNA and oxidative stress were induced; the cells ability to repair DNA was impaired. [51,52]
TiO2-based nanofilamentsHuman lung tumor cells (H596)0.01, 0.1, 1, and 2 μg/mLTiO2-based nanofilaments (2 μg/mL) impaired cell proliferation and cell death in a dose-dependent manner; The short (<5 μm) needle-like structures were taken up by H596 cells and clustered and gathered around the cell nucleus.[53]
TiO2 nanobelts: short (<5 μm) long (>15 μm)Primary murine alveolar macrophages100 μg/mLThe 15-μm nanobelts were highly toxic, involving the loss of lysosomal integrity and the release of cathepsin B. These fiber-shaped nanomaterials induced inflammasome activation and the release of inflammatory cytokines in a manner very similar to asbestos or silica.[54]
0-D TiO2 nanoparticles, 1-D TiO2 nanorods, 3-D TiO2 assembliesHeLa cells125 μg/mL0-D anatase NPs decreased cell viability to a level of 80% at 125 μg/mL, and cell viability of 1-D and 3-D structures remained close to 100%; 0-D TiO2 NPs and 1-D nanorods could be readily internalized into the cells and the spherical particles were taken up more than the rod-shaped particles of similar size; 3-D assembled aggregates of TiO2 were less likely to be incorporated into cells.[55]
Anatase/rutile spheres (TiO2-P25), anatase spheres (TiO2-A), anatase nanobelts (TiO2-NBs)Human monocyte/macrophage cell line (THP-1)10, 25, 50, and 100 μg/mL for 24 hTiO2 was not cytotoxic except for the nanobelt form, which was cytotoxic and induced significant IL-1β production in THP-1 cells.[56]
Anatase and rutile TiO2 NPsA549 Anatase TiO2 produced greater cell responses and was more toxic than rutile by MTT and XTT assay. Differences in biological response of NPs occurred as a function of size, crystalline phase and chemical composition.[57]
Nanocrystalline TiO2 (anatase and rutile)A549 and human dermal fibroblasts (HDF) cell line100 μg/mLAnatase was 2 orders of magnitude more cytotoxic (LC50 of 3.6 µg/mL) than similarly sized rutile counterparts (LC50 of 550 µg/mL) by determining cell viability and LDH release; The most cytotoxic NPs were the most effective for generating ROS, and were more likely to generate damaging RS species in cell culture.[58]
Nanosized anatase (<25 nm), nano-sized rutile with SiO2 coating, and fine rutile (<5 µm)BEAS-2B, Chinese hamster lung fibroblast (V79) cells1–100 μg/cm2 for 24, 48, and 72 hNano-sized anatase and fine rutile induced DNA damage at doses of 1 and 10 μg/cm2, while SiO2-coated rutile induced DNA damage only at 100 μg/cm2. Only nanosized anatase could elevate the frequency of micronucleated BEAS-2B cells.[59,60]
Anatase and rutile TiO2 NPs (6.3, 10, 50, and 100 nm)Mouse keratinocyte cell line (HEL-30)0, 10, 25, 50, 100, and 150 μg/mL for 24 hAnatase TiO2 NPs could induce cell necrosis, whereas rutile TiO2 NPs could initiate apoptosis through the formation of ROS.[61]
Uncoated TiO2 (anatase and rutile), polyacrylate-coated nano-TiO2Chinese hamster lung fibroblast (V79) cells10 and 100 mg/L for 24 hBoth coated and uncoated TiO2 (anatase and rutile) decreased the cell viability in a mass- and size-dependent manner; TiO2 NPs coated with polyacrylate were only cytotoxic at high concentration (100 mg/L), and only uncoated nano-TiO2 induced DNA damage.[60]
Functionalized TiO2 NPs with various surface groups (–OH, −NH2, and –COOH)Lewis lung carcinoma, 3T3 fibroblasts0.01, 0.1, 1, and 10 mg/L for 24 h–NH2 and –OH groups showed significantly higher toxicity than –COOH; the decreased cell viability was associated with TiO2 particles-induced protein aggregation/denaturation and subsequent impaired cell membrane function.[62]
Rutile (<5 μm), nanosized rutile/anatase (~30 nm), nanosized anatase (<25 nm), silica-coated nanosized needle-like rutile (~10 × 40 nm) (cnTiO2)Murine macrophages RAW 264.7; Human pulmonary fibroblasts (MRC-9)20, 30, 100, 300 μg/mL for 6 hcnTiO2 elicited significant induction of TNF-α and neutrophil-attracting chemokines. Stimulation of human fibroblasts with cnTiO2-activated macrophage supernatant induced high expression of neutrophil-attracting chemokines, CXCL1 and CXCL8.[45]
Pure anatase and rutile TiO2Human alveolar type-I-like epithelial cell (TTI) These two nano-TiO2 forms mediated a similar profile and pattern of inflammatory response; pure rutile caused a small, but consistently greater response for IL-6, IL-8 and MCP-1; the temporal induction of oxidative stress varied markedly between the two nano-TiO2 forms.[63]
At the nano level, TiO2 NPs at a given size can agglomerate in different sizes and structures. Influence of the agglomeration of TiO2 NPs on pulmonary toxicity has been investigated by Noël et al. [64,65,66]. One study reported that rats exposed to small agglomerates (<100 nm) of 5 nm TiO2 by inhalation showed greater cytotoxic and oxidative stress responses than rats exposed to larger agglomerates (>100 nm) of the same NPs, which only induced a slight inflammatory reaction [64]. In a follow-up study, the authors compared the agglomeration state with different primary sizes of TiO2 NPs (5, 10–30 and 50 nm) [66]. The results showed that for an agglomeration state smaller than 100 nm, the 5-nm particles caused a significant increase of LDH activity (cytotoxic effects) compared to controls, while oxidative damage measured by 8-isoprostane concentration was less when compared to 10-, 30- and 50-nm particles. This indicates that the initial particle size and agglomeration state of TiO2 NPs are important factors for the lung inflammatory reaction and cytotoxic and oxidative stress responses.

2.2. Shape

TiO2 NPs or nanospheres are generally considered to have cytotoxicity effects, which have been thoroughly assessed and published. Jugan et al. [51,52] reported that spherical TiO2 NPs (12–140 nm; both anatase and rutile) induced single strand breaks, oxidative lesions to DNA and oxidative stress in A549 cells (human lung carcinoma epithelial cell line). They also showed that TiO2 NPs impair the cells ability to repair DNA by deactivating both the nucleotide excision repair (NER) and the base excision repair (BER) pathways.
Other than zero-dimensional TiO2 NPs (nanospheres), one-dimensional TiO2 nanostructures are the most synthesized and widely used including nanorods, nanobelts, and nanotubes, etc. The shape of TiO2 NPs has an effect on their deposition in the lung. The exposure of mice to various shapes of anatase TiO2 (nanospheres, short belts of 1–5 μm, and long nanobelts of 4–12 μm) resulted in the lung deposition of 135 μg for the animals exposed to both nanospheres and long nanobelts. At 112 day after exposure, the lung burden was significantly lower in nanosphere-exposed mice than in nanobelt-exposed mice [39]. Several works report the interaction of NP shape with lung tissue or pulmonary cells. In a study of rutile TiO2 nanorods, inflammation responses were examined in BALF (significantly increased neutrophilic inflammation) and whole blood (significantly reduced platelets and elevated numbers of monocytes and granulocytes) in Wistar rats 24 h after intratracheal instillation at doses of 1 or 5 mg/kg [40]. Warheit et al. [41] showed that instilled nanoscale TiO2 rods (anatase = 200 nm × 35 nm) and nanoscale TiO2 dots (anatase = similar to 10 nm) produced transient lung inflammation and cell injury in rats at 24 h post-exposure, which is similar to the pulmonary effects of rutile TiO2 NPs (300 nm). The cytotoxic effect of TiO2-based nanofilaments on H596 human lung tumor cells have been evaluated [53]. The addition of TiO2-based nanofilaments (2 μg/mL) impaired cell proliferation and cell death in a dose-dependent manner. The short (<5 μm) needle-like structures were taken up by H596 cells and clustered around the cell nucleus. Hamilton et al. [54] synthesized the short (<5 μm) and long (>15 μm) TiO2 nanobelts and tested their biological activity using primary murine alveolar macrophages and mice. The 15-μm nanobelts were highly toxic, involving the loss of lysosomal integrity and the release of cathepsin B. These fiber-shaped nanomaterials induced the inflammasome activation and the release of inflammatory cytokines in a manner very similar to asbestos or silica. At the lowest-observed-effect level (LOEL), only the anatase TiO2 nanobelt displayed significant inflammation in the BALF of Sprague Dawley (SD) rats 1 day after intratracheal instillation compared with anatase/rutile P25 spheres (TiO2-P25) and pure anatase spheres [42]. The various morphological classes of TiO2 nanostructures, including zero-, one-, and three-dimensional (0-D, 1-D, and 3-D) anatase assemblies, have been evaluated [55]. At a concentration of 125 μg/mL, 0-D anatase NPs decreased cell viability to a level of 80%, and the cell viability of 1-D and 3-D structures remained close to 100%. The cellular uptake experiment showed that 1-D nanorods and 0-D TiO2 NPs could be readily internalized into the cells after 24 h incubation. The spherical particles were taken up more than the rod-shaped particles of similar size. The more sterically unwieldy, highest surface area 3-D aggregates of TiO2 were less likely to be incorporated into cells. The National Institute of Environmental Health Science (NIEHS) Nano GO Consortium conducted a series of coordinated inter-laboratory research with different shapes of TiO2 both in vitro and in vivo. The results showed that only the TiO2 nanobelt form was toxic; it induced significant IL-1β production in THP-1 (human monocyte/macrophage cell line) cells, and caused significant neutrophilia in mice and rats at 1 day after intratracheal instillation in two or three of four labs. However, no significant toxicity effect was observed in vitro for TiO2 spheres in any of the labs [43,56].

2.3. Crystal Phase

Anatase and rutile have different crystal lattices. Rutile is considered as an inert form, whereas anatase is an active form of TiO2 with a high refractive index and low scattering and strong absorption of ultraviolet (UV) radiation. Based on crystal structure as the mediating property, nanotoxicity studies examining the effects of TiO2 have shown the induction of inflammatory responses, cytotoxicity and reactive oxygen species (ROS) formation. Ferin et al. [67] exposed rats to an aerosol of either anatase or rutile by intratracheal instillation in doses of 0.5 or 5.0 mg/rat and determined the TiO2 retention in the lung up to 132 days post-exposure. They found that both anatase and rutile TiO2 yielded similar results in lung response such as AM, peroxidase positive AM, and PMN leukocytes. Although both anatase and rutile TiO2 NPs could be taken up into cells, located in the cytoplasm, and isolated in vacuoles, the cytotoxicity of NPs depends, to some extent, on crystalline structure. Anatase TiO2 NPs are found to produce greater cell responses and to be more toxic than rutile TiO2 by MTT and XTT assay [57]. Using the A549 and HDF cell lines, Sayes et al. demonstrated that catalytically active anatase was 2 orders of magnitude more cytotoxic (LC50 of 3.6 µg/mL) than its similarly sized rutile counterpart (LC50 of 550 µg/mL) by determining cell viability and LDH release [58]. The profile and pattern of inflammatory mediator release and temporal induction of oxidative stress were determined using TiO2 NPs synthesized specifically for toxicological study and a highly relevant human lung cell model, The authors showed that it was a useful approach to delineating the physiochemical properties of nanomaterials in cellular reactivity [63].
The genotoxicity of nanosized anatase (<25 nm), nanosized rutile with SiO2 coating, and fine rutile (<5 μm) in human BEAS-2B cells was assessed by Falck et al. [59]. Nanosized anatase and fine rutile induced DNA damage at the doses of 1 and 10 μg/cm2, while SiO2-coated rutile induced DNA damage only at 100 μg/cm2. Only nanosized anatase could elevate the frequency of micronucleated BEAS-2B cells. Another study showed a similar result. The anatase nano-TiO2 caused a stronger induction of DNA damage than rutile in Chinese hamster lung fibroblast (V79) cells as determined by comet assay [60].
In addition, there are several papers about the cytotoxicity of rutile and anatase TiO2 NPs in other cell lines. Braydich-Stolle et al. [61] reported that anatase TiO2 NPs, regardless of size, could induce cell necrosis, whereas rutile TiO2 NPs could initiate apoptosis through the formation of ROS. The correlation between crystal phase and oxidant capacity was established using TiO2 NPs of 11 different crystal phase combinations at similar sizes [68]. The ability of anatase TiO2 NPs to generate ROS was higher than anatase/rutile mixtures and rutile samples.

2.4. Surface Coating

In commercial applications of TiO2, surface coating with inorganic or organic substances is often used to facilitate dispersion, solubility, UV protection, wearing and plastics. The toxicity of coated TiO2 has been evaluated by many researchers, and it is well known that nanomaterial interactions with biology are dictated by the chemical functionalities on the surface in addition to their shape and size. Hydrophobic ultrafine TiO2 coated with a silane compound was initially reported to be highly toxic and lethal when administrated to rats by intratracheal injection [69]. Since then, the surface coating of TiO2 with aluminum oxide and/or silica has been shown to produce higher pulmonary inflammation (PMNs in BALF) than the uncoated TiO2 at 24 h in SD rats administered a large dose of 10 mg/kg [44], but this effect was only a short-term, transient lung inflammatory response and was reversible at one week post-exposure. A similar result was observed with TiO2 particles having a silane coating (hydrophobic) compared to uncoated TiO2 (hydrophilic). Rossi et al. [45] showed that only SiO2-coated rutile commercial TiO2 NPs elicited clear-cut pulmonary neutrophilia, increased expression of tumor necrosis factor (TNF)-α and neutrophil-attracting chemokines both in vivo (BALB/c mice, by inhalation at 10 mg/m3) and in vitro (RAW264.7 and human pulmonary fibroblasts MRC-9 cells). They concluded that the level of lung inflammation could not be explained by the surface area of the particles, their primary or agglomerate particle size, or free radical formation capacity but rather by the surface coating. Oberdorster et al. reported, however, that 500 μg hydrophobic and silanized ultrafine TiO2 did not show toxicity, but a much lower pulmonary inflammation was induced in comparison to the hydrophilic uncoated TiO2 in rat lung [46]. The incorporation of TiO2 NPs in aged paint matrix blocked most of the particle-induced lung and systemic blood toxicity in BALB/c mice [47]. The rutile TiO2 NPs coated with alumina (uf-1) and silica/alumina (uf-2) produced transient lung inflammation in rats exposed by intratracheal instillation at doses of 1 or 5 mg/kg, and uncoated anatase/rutile TiO2 (uf-3) induced cytotoxicity and aggregated macrophages in the alveolar regions of the lung. This occurred because uf-3 particles showed more chemical reactivity than both uf-1 and uf-2 particles [48]. At low doses, surface-coated rutile TiO2 deposited in the mice lung may potentially perturb several gene expression associated with ion homeostasis and muscle function in the absence of inflammation [27].
The cytotoxicity and genotoxicity of coated and uncoated TiO2 particles were recently reported using Chinese hamster lung fibroblast (V79) cells [60]. The authors found that both coated and uncoated TiO2 (anatase and rutile) decreased the cell viability in a mass- and size-dependent manner, although the TiO2 NPs coated with polyacrylate were only cytotoxic at high concentration (100 mg/L), and only uncoated nano-TiO2 induced DNA damage. Rehn et al. [49] determined that there was no inflammation or persistent DNA damage in the lung of rats exposed to two types of commercial TiO2 (untreated with hydrophilic surface and silanized with a hydrophobic surface) at low doses (a single dose of 0.15, 0.3, 0.6 and 1.2 mg) by instillation. Methylated TiO2 particles induced a lesser inflammatory response (influx of neutrophils and total cell number) in rats after intratracheal instillation in comparison to the untreated TiO2, and the impact of surface methylation on TiO2 toxicity was negligible [50]. However, the question remains: what is the underlying mechanism? Thevenot et al. tested the cytotoxicity effect of functionalized TiO2 NPs with various surface groups (–OH, –NH2, and –COOH) and reported that the decreased viability of TiO2 NPs on lung epithelial cells was associated with TiO2 particles-induced protein aggregation/denaturation and subsequent impaired cell membrane function [62]. Thus, it can be seen that surface treatment can influence the toxicity of TiO2 particles in the lung, and the pulmonary toxicity and cytotoxicity of coated TiO2 NPs might be related to surface chemical activity because of different surface coatings [62].

2.5. ROS Mechanism in Lung Toxicity of TiO2 NPs

Inhaled TiO2 NPs show considerably stronger pulmonary inflammatory effects and the mechanism that has been suggested to be involved included ROS production as a hallmark in TiO2 NP toxicity [2,5,70,71], especially under exposure to light or UV. Sayes et al. [58] detected that photoactivated TiO2 produced greater ROS and resulted in cytotoxicity. This effect is better described by the crystal structure and the specific surface area than mass dose.
Anatase TiO2 NPs are capable of reacting with a wide range of organic and biological molecules and are more prone to generate ROS than the rutile form. At the cellular level, ROS may be generated directly by particle structures in or near the cell or may arise more indirectly due to the effects of internalized particles on mitochondrial respiration or the depletion of antioxidant species within the cell. In an in vitro cell assay, Bhattacharya et al. [72] reported that anatase TiO2 particles with diameters <100 nm were able to generate elevated amounts of free radicals and induced DNA-adduct formation (8-OHdG) but not DNA-breakage after uptake by human lung fibroblasts (IMR-90) and BEAS-2B. The anatase TiO2 NPs (50, 100, 200 and 300 μg/mL) induced dose-dependent mitochondrial injury and ATP synthesis prevention in A549 cells owing to the over-generation of ROS [73]. The radical generation driven by the surface area of TiO2 NPs in A549 cells was investigated by Singh et al. [74]. They observed that the commercial TiO2 NPs elicited significant increased ROS generation during cell treatment and indicated that the higher specific surface area of particles caused oxidative stress in A549 cells rather than hydrophobicity [74]. In a rapid cell-free pre-screening assay, Jiang et al. [68] investigated the role of crystal structure and surface area on particle ROS generation and established that size, surface area, and crystal structure all contribute to ROS generation. ROS generation was associated with the number of defect sites per surface area, and an S-shaped curve was observed as a function of particle size. The ability of TiO2 NPs to generate ROS was amorphous > anatase > anatase/rutile mixtures > rutile.
ROS are also produced by lung AM and inflammatory cells during overloading and immunological responses of the lung to inhaled TiO2 NPs. When antioxidant defenses are overwhelmed, oxidative stress can occur and is considered an underlying mechanism of the proliferative and genotoxic responses to inhaled TiO2 NPs. Sun et al. [75] investigated that TiO2 NPs significantly accumulated and increased ROS production (elevated O2, H2O2) in mouse lung by intratracheal administration with increasing exposure term. The exposure of human and rodents AM to TiO2 NPs caused extracellular ROS generation, resulted in increased TNF-α release, heme oxygenase (HO)-1 mRNA and inducible nitric oxide synthase (iNOS) mRNA expression, and induced an increase in the expression of nuclear factor erythroid 2 related factor 2 (Nrf 2) to adapt intracellular responses to TiO2-induced oxidative stress [45,76,77,78]. Xia et al. [77] concluded that the surface properties of NPs and their interactions with cellular components were capable of generating oxidative stress.

3. Conclusions

Nanoparticles generate great benefits, as well as some potential risks, to human health. Owing to the small size, coupled with the unique physical and chemical properties of NPs, nanotoxicology is put forward by some pioneer scientists to specifically address the problems likely to be caused by nanoparticles/nanomaterials in terms of their potential adverse health effects. In bulk, TiO2 is considered to be low toxicity and is widely used in many fields. However, at nanoscale, TiO2 can deposit in the alveolar region and access the lung interstitium after inhalation exposure, eliciting a pulmonary inflammatory response and lung injury.
In this paper, an overview of the lung injury and cytotoxicity of TiO2 NPs correlated with the physicochemical properties, including size, shape, crystal structure and surface coating is presented. Mass dose is traditionally viewed as the key factor in toxicity studies. However, the biological activity of NPs strongly depends on physicochemical parameters but not on routinely considered in toxicity screening. The unique characteristics of NPs are predominantly associated with their nanoscale structure, size, shape and structure-dependent electronic configurations and an extremely large surface-to-volume ratio relative to bulk materials. The nano size with a high aspect ratio (nanorod, nanobelt, nanofilament) determines the high reactivity of NPs, which enables the insoluble TiO2 NPs to agglomerate and affect cellular uptake and lung injury. Because of the different crystal lattices, anatase TiO2 induces greater ROS production and cell responses and is more toxic than rutile due to the active sites on its surface. The coating of TiO2 with silica and alumina can reduce the pulmonary inflammatory response and cytotoxicity to a certain extent. Lastly, the correlation of ROS production in pulmonary toxicity with properties of TiO2 NPs was briefly described.
Nanotoxicology and the biological effects of NPs have become hot topics in many fields. When evaluating the potential biological effects of NPs and elucidating their mechanisms for toxicity screening, the size, crystal phase, dispersion and agglomeration status, coating, and chemical composition should be most appropriately characterized.

Acknowledgments

This work was financially supported by the National Key Technology R&D Program of China (973 Program, 2011CB710901), the National Natural Science Foundation of China (NSFC) Research Grant (31271008, 11120101001, 61227902, 11421202), the 111 Project (B13003), the International Joint Research Center of Aerospace Biotechnology and the Medical Engineering, Ministry of Science and Technology of China, Specialized Research Fund for the Doctoral Program of Higher Education, and National High Technology Research and Development Program of China (863 program, 2011AA02A102).

Author Contributions

Conception and design: Yubo Fan, Jiangxue Wang; Data collection and analysis: Jiangxue Wang; Drafting of manuscript: Jiangxue Wang; Critical revisions/Supervision: Yubo Fan.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Chusuei, C.C.; Wu, C.H.; Mallavarapu, S.; Hou, F.Y.; Hsu, C.M.; Winiarz, J.G.; Aronstam, R.S.; Huang, Y.W. Cytotoxicity in the age of nano: The role of fourth period transition metal oxide nanoparticle physicochemical properties. Chem. Biol. Interact. 2013, 206, 319–326. [Google Scholar] [PubMed]
  2. Nel, A.; Xia, T.; Madler, L.; Li, N. Toxic potential of materials at the nanolevel. Science 2006, 311, 622–627. [Google Scholar] [CrossRef] [PubMed]
  3. Donaldson, K.; Stone, V.; Tran, C.L.; Kreyling, W.; Borm, P.J.A. Nanotoxicology: A new frontier in particle toxicology relevant to both the workplace and general environment and to consumer safety. Occup. Environ. Med. 2004, 61, 727–728. [Google Scholar] [CrossRef] [PubMed]
  4. Colvin, V.L. The potential environmental impact of engineered nanomaterials. Nat. Nanotechnol. 2003, 21, 1166–1170. [Google Scholar]
  5. Oberdorster, G.; Oberdorster, E.; Oberdorster, J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113, 823–839. [Google Scholar] [CrossRef] [PubMed]
  6. Diebold, U. The surface science of titanium dioxide. Surf. Sci. Rep. 2003, 48, 53–229. [Google Scholar] [CrossRef]
  7. Warheit, D.B.; Hoke, R.A.; Finlay, C.; Donner, E.M.; Reed, K.L.; Sayes, C.M. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol. Lett. 2007, 171, 99–110. [Google Scholar] [CrossRef] [PubMed]
  8. Wang, J.; Zhou, G.; Chen, C.; Yu, H.; Wang, T.; Ma, Y.; Jia, G.; Gao, Y.; Li, B.; Sun, J. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol. Lett. 2007, 168, 176–185. [Google Scholar] [CrossRef] [PubMed]
  9. Wang, J.X.; Chen, C.Y.; Yu, H.W.; Sun, J.; Li, B.; Li, Y.F.; Gao, Y.X.; He, W.; Huang, Y.Y.; Chai, Z.F.; et al. Distribution of TiO2 particles in the olfactory bulb of mice after nasal inhalation using microbeam SRXRF mapping techniques. J. Radioanal. Nucl. Chem. 2007, 272, 527–531. [Google Scholar] [CrossRef]
  10. Ferin, J.; Oberdörster, G.; Penney, D.P. Pulmonary retention of ultrafine and fine particles in rats. Am. J. Respir. Cell Mol. Biol. 1992, 6, 535–542. [Google Scholar] [CrossRef] [PubMed]
  11. Oesch, F.; Landsiedel, R. Genotoxicity investigations on nanomaterials. Arch. Toxicol. 2012, 86, 985–994. [Google Scholar] [CrossRef] [PubMed]
  12. The National Institute for Occupational Safety and Health (NIOSH). NIOSH Current Intelligence Bulletin 63: Occupational Exposure to Titanium Dioxide; NIOSH publication: Atlanta, GA, USA, 2011. [Google Scholar]
  13. Boffetta, P.; Soutar, A.; Cherrie, J.W.; Granath, F.; Andersen, A.; Anttila, A.; Blettner, M.; Gaborieau, V.; Klug, S.J.; Langard, S.; et al. Mortality among workers employed in the titanium dioxide production industry in Europe. Cancer Causes Control. 2004, 15, 697–706. [Google Scholar] [CrossRef] [PubMed]
  14. Hext, P.M.; Tomenson, J.A.; Thompson, P. Titanium dioxide: Inhalation toxicology and epidemiology. Ann. Occup. Hyg. 2005, 49, 461–472. [Google Scholar] [CrossRef] [PubMed]
  15. Pope, C.A., III. Epidemiology of fine particulate air pollution and human health: Biologic mechanisms and whoʼs at risk? Environ. Health Perspect. 2000, 108, 713–723. [Google Scholar] [CrossRef] [PubMed]
  16. Baan, R.; Straif, K.; Grosse, Y.; Secretan, B.A.; el Ghissassi, F.; Cogliano, V. Carcinogenicity of carbon black, titanium dioxide, and talc. Lancet Oncol. 2006, 7, 295–296. [Google Scholar] [CrossRef]
  17. Bermudez, E.; Mangum, J.B.; Asgharian, B.; Wong, B.A.; Reverdy, E.E.; Janszen, D.B.; Hext, P.M.; Warheit, D.B.; Everitt, J.I. Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles. Toxicol. Sci. 2002, 70, 86–97. [Google Scholar] [CrossRef] [PubMed]
  18. Bermudez, E.; Mangum, J.B.; Wong, B.A.; Asgharian, B.; Hext, P.M.; Warheit, D.B.; Everitt, J.I. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol. Sci. 2004, 77, 347–357. [Google Scholar] [CrossRef] [PubMed]
  19. Henderson, R.F.; Driscoll, K.E.; Harkema, J.R.; Lindenschmidt, R.C.; Chang, I.Y.; Maples, K.R.; Barr, E.B. A comparison of the inflammatory response of the lung to inhaled versus instilled particles in F344 rats. Fundam. Appl. Toxicol. 1995, 24, 183–197. [Google Scholar] [CrossRef] [PubMed]
  20. Oberdorster, G.; Ferin, J.; Gelein, R.; Soderholm, S.C.; Finkelstein, J. Role of the alveolar macrophage in lung injury: Studies with ultrafine particles. Environ. Health Perspect. 1992, 97, 193–199. [Google Scholar] [CrossRef] [PubMed]
  21. Oberdorster, G.; Finkelstein, J.N.; Johnston, C.; Gelein, R.; Cox, C.; Baggs, R.; Elder, A.C. Acute pulmonary effects of ultrafine particles in rats and mice. Health Effects Inst. Res. Rep. 2000, 96, 5–74. [Google Scholar]
  22. Osier, M.; Oberdorster, G. Intratracheal inhalation vs intratracheal instillation: Differences in particle effects. Fundam. Appl. Toxicol. 1997, 40, 220–227. [Google Scholar] [CrossRef] [PubMed]
  23. Osier, M.; Baggs, R.B.; Oberdorster, G. Intratracheal instillation versus intratracheal inhalation: Influence of cytokines on inflammatory response. Environ. Health Perspect. 1997, 105, 1265–1271. [Google Scholar] [CrossRef] [PubMed]
  24. Warheit, D.B.; Hansen, J.F.; Yuen, I.S.; Kelly, D.P.; Snajdr, S.I.; Hartsky, M.A. Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation. Toxicol. Appl. Pharmacol. 1997, 145, 10–22. [Google Scholar] [CrossRef] [PubMed]
  25. Donaldson, K.; Li, X.Y.; MacNee, W. Ultrafine (nanometre) particle mediated lung injury. J. Aerosol Sci. 1998, 29, 553–560. [Google Scholar] [CrossRef]
  26. Ma-Hock, L.; Burkhardt, S.; Strauss, V.; Gamer, A.O.; Wiench, K.; van Ravenzwaay, B.; Landsiedel, R. Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance. Inhal. Toxicol. 2009, 21, 102–118. [Google Scholar] [PubMed]
  27. Husain, M.; Saber, A.T.; Guo, C.; Jacobsen, N.R.; Jensen, K.A.; Yauk, C.L.; Williams, A.; Vogel, U.; Wallin, H.; Halappanavar, S. Pulmonary instillation of low doses of titanium dioxide nanoparticles in mice leads to particle retention and gene expression changes in the absence of inflammation. Toxicol. Appl. Pharmacol. 2013, 269, 250–262. [Google Scholar] [CrossRef] [PubMed]
  28. Shi, H.; Magaye, R.; Castranova, V.; Zhao, J. Titanium dioxide nanoparticles: A review of current toxicological data. Part. Fibre Toxicol. 2013, 10, 15. [Google Scholar] [CrossRef] [PubMed]
  29. Verma, A.; Stellacci, F. Effect of surface properties on nanoparticle-cell interactions. Small 2010, 6, 12–21. [Google Scholar] [CrossRef] [PubMed]
  30. Iavicoli, I.; Leso, V.; Fontana, L.; Bergamaschi, A. Toxicological effects of titanium dioxide nanoparticles: A review of in vitro mammalian studies. Eur. Rev. Med. Pharmacol. Sci. 2011, 15, 481–508. [Google Scholar]
  31. Hsieh, T.H.; Yu, C.P.; Oberdorster, G. Modeling of deposition and clearance of inhaled Ni compounds in the human lung. Regul. Toxicol. Pharmacol. 1999, 30, 18–28. [Google Scholar] [CrossRef] [PubMed]
  32. ICRP. ICRP Publication 66: Human Respiratory Tract Model for Radiological Protection, 66th ed.; Elsevier Health Sciences: Oxford, UK, 1994. [Google Scholar]
  33. Renwick, L.C.; Donaldson, K.; Clouter, A. Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol. Appl. Pharm. 2001, 172, 119–127. [Google Scholar] [CrossRef]
  34. Oberdorster, G.; Ferin, J.; Lehnert, B.E. Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect. 1994, 102, 173–179. [Google Scholar] [CrossRef]
  35. Gibbs-Flournoy, E.A.; Bromberg, P.A.; Hofer, T.P.; Samet, J.M.; Zucker, R.M. Darkfield-confocal microscopy detection of nanoscale particle internalization by human lung cells. Part. Fibre Toxicol. 2011, 8, 2. [Google Scholar] [CrossRef] [PubMed]
  36. Chen, H.W.; Su, S.F.; Chien, C.T.; Lin, W.H.; Yu, S.L.; Chou, C.C.; Chen, J.J.; Yang, P.C. Titanium dioxide nanoparticles induce emphysema-like lung injury in mice. FASEB J. 2006, 20, 2393–2395. [Google Scholar] [CrossRef] [PubMed]
  37. Hubbard, A.K.; Timblin, C.R.; Shukla, A.; Rincón, M.; Mossman, B.T. Activation of NF-κB-dependent gene expression by silica in lungs of luciferase reporter mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 282, L968–L975. [Google Scholar] [PubMed]
  38. Gurr, J.-R.; Wang, A.S.S.; Chen, C.-H.; Jan, K.-Y. Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicology 2005, 213, 66–73. [Google Scholar] [CrossRef] [PubMed]
  39. Porter, D.W.; Wu, N.; Hubbs, A.F.; Mercer, R.R.; Funk, K.; Meng, F.; Li, J.; Wolfarth, M.G.; Battelli, L.; Friend, S.; et al. Differential mouse pulmonary dose and time course responses to titanium dioxide nanospheres and nanobelts. Toxicol. Sci. 2013, 131, 179–193. [Google Scholar] [CrossRef] [PubMed]
  40. Nemmar, A.; Melghit, K.; Ali, B.H. The acute proinflammatory and prothrombotic effects of pulmonary exposure to rutile TiO2 nanorods in rats. Exp. Biol. Med. 2008, 233, 610–619. [Google Scholar] [CrossRef]
  41. Warheit, D.B.; Webb, T.R.; Sayes, C.M.; Colvin, V.L.; Reed, K.L. Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: Toxicity is not dependent upon particle size and surface area. Toxicol. Sci. 2006, 91, 227–236. [Google Scholar] [CrossRef] [PubMed]
  42. Silva, R.M.; Teesy, C.; Franzi, L.; Weir, A.; Westerhoff, P.; Evans, J.E.; Pinkerton, K.E. Biological response to nano-scale titanium dioxide (TiO2): Role of particle dose, shape, and retention. J. Toxicol. Environ. Health A 2013, 76, 953–972. [Google Scholar] [CrossRef] [PubMed]
  43. Bonner, J.C.; Silva, R.M.; Taylor, A.J.; Brown, J.M.; Hilderbrand, S.C.; Castranova, V.; Porter, D.; Elder, A.; Oberdorster, G.; Harkema, J.R.; et al. Interlaboratory evaluation of rodent pulmonary responses to engineered nanomaterials: The NIEHS Nano GO Consortium. Environ. Health Perspect. 2013, 121, 676–682. [Google Scholar] [CrossRef] [PubMed]
  44. Warheit, D.B.; Brock, W.J.; Lee, K.P.; Webb, T.R.; Reed, K.L. Comparative pulmonary toxicity inhalation and instillation studies with different TiO2 particle formulations: Impact of Surface Treatments on Particle Toxicity. Toxicol. Sci. 2005, 88, 514–524. [Google Scholar] [CrossRef] [PubMed]
  45. Rossi, E.M.; Pylkkänen, L.; Koivisto, A.J.; Vippola, M.; Jensen, K.A.; Miettinen, M.; Sirola, K.; Nykäsenoja, H.; Karisola, P.; Stjernvall, T.; et al. Airway exposure to silica-coated TiO2 nanoparticles induces pulmonary neutrophilia in mice. Toxicol. Sci. 2010, 113, 422–433. [Google Scholar] [CrossRef] [PubMed]
  46. Oberdorster, G. Pulmonary effects of inhaled ultrafine particles. Int. Arch. Occup. Environ. Health 2001, 74, 1–8. [Google Scholar] [CrossRef] [PubMed]
  47. Smulders, S.; Luyts, K.; Brabants, G.; Landuyt, K.V.; Kirschhock, C.; Smolders, E.; Golanski, L.; Vanoirbeek, J.; Hoet, P.H. Toxicity of nanoparticles embedded in paints compared with pristine nanoparticles in mice. Toxicol. Sci. 2014, 141, 132–140. [Google Scholar] [CrossRef] [PubMed]
  48. Warheit, D.B.; Webb, T.R.; Reed, K.L.; Frerichs, S.; Sayes, C.M. Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: Differential responses related to surface properties. Toxicology 2007, 230, 90–104. [Google Scholar] [CrossRef] [PubMed]
  49. Rehn, B.; Seiler, F.; Rehn, S.; Bruch, J.; Maier, M. Investigations on the inflammatory and genotoxic lung effects of two types of titanium dioxide: Untreated and surface treated. Toxicol. Appl. Pharmacol. 2003, 189, 84–95. [Google Scholar] [CrossRef] [PubMed]
  50. Hohr, D.; Steinfartz, Y.; Schins, R.P.; Knaapen, A.M.; Martra, G.; Fubini, B.; Borm, P.J. The surface area rather than the surface coating determines the acute inflammatory response after instillation of fine and ultrafine TiO2 in the rat. Int. J. Hyg. Environ. Health 2002, 205, 239–244. [Google Scholar] [CrossRef] [PubMed]
  51. Jugan, M.L.; Barillet, S.; Simon-Deckers, A.; Sauvaigo, S.; Douki, T.; Herlin, N.; Carrière, M. Cytotoxic and genotoxic impact of TiO2 nanoparticles on A549 cells. J. Biomed. Nanotechnol. 2011, 7, 22–23. [Google Scholar] [CrossRef] [PubMed]
  52. Jugan, M.-L.; Barillet, S.; Simon-Deckers, A.; Herlin-Boime, N.; Sauvaigo, S.; Douki, T.; Carriere, M. Titanium dioxide nanoparticles exhibit genotoxicity and impair DNA repair activity in A549 cells. Nanotoxicology 2012, 6, 501–513. [Google Scholar] [CrossRef] [PubMed]
  53. Magrez, A.; Horvath, L.; Smajda, R.; Salicio, V.; Pasquier, N.; Forro, L.; Schwaller, B. Cellular toxicity of TiO2-based nanofilaments. ACS Nano 2009, 3, 2274–2280. [Google Scholar] [CrossRef] [PubMed]
  54. Hamilton, R.F.; Wu, N.; Porter, D.; Buford, M.; Wolfarth, M.; Holian, A. Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part. Fibre Toxicol. 2009, 6, 35. [Google Scholar] [CrossRef] [PubMed]
  55. Chen, J.; Zhou, H.; Santulli, A.C.; Wong, S.S. Evaluating cytotoxicity and cellular uptake from the presence of variously processed TiO2 nanostructured morphologies. Chem. Res. Toxicol. 2010, 23, 871–879. [Google Scholar] [CrossRef] [PubMed]
  56. Xia, T.; Hamilton, R.F.; Bonner, J.C.; Crandall, E.D.; Elder, A.; Fazlollahi, F.; Girtsman, T.A.; Kim, K.; Mitra, S.; Ntim, S.A.; et al. Interlaboratory evaluation of in vitro cytotoxicity and inflammatory responses to engineered nanomaterials: The NIEHS Nano GO Consortium. Environ. Health Perspect. 2013, 121, 683–690. [Google Scholar] [CrossRef] [PubMed]
  57. Simon-Deckers, A.; Gouget, B.; Mayne-L’Hermite, M.; Herlin-Boime, N.; Reynaud, C.; Carrière, M. In vitro investigation of oxide nanoparticle and carbon nanotube toxicity and intracellular accumulation in A549 human pneumocytes. Toxicology 2008, 253, 137–146. [Google Scholar] [CrossRef] [PubMed]
  58. Sayes, C.M.; Wahi, R.; Kurian, P.A.; Liu, Y.P.; West, J.L.; Ausman, K.D.; Warheit, D.B.; Colvin, V.L. Correlating nanoscale titania structure with toxicity: A cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol. Sci. 2006, 92, 174–185. [Google Scholar] [CrossRef] [PubMed]
  59. Falck, G.; Lindberg, H.; Suhonen, S.; Vippola, M.; Vanhala, E.; Catalán, J.; Savolainen, K.; Norppa, H. Genotoxic effects of nanosized and fine TiO2. Hum. Exp. Toxicol. 2009, 28, 339–352. [Google Scholar] [CrossRef] [PubMed]
  60. Hamzeh, M.; Sunahara, G.I. In vitro cytotoxicity and genotoxicity studies of titanium dioxide (TiO2) nanoparticles in Chinese hamster lung fibroblast cells. Toxicol. Vitro 2013, 27, 864–873. [Google Scholar] [CrossRef]
  61. Braydich-Stolle, L.; Schaeublin, N.; Murdock, R.; Jiang, J.; Biswas, P.; Schlager, J.; Hussain, S. Crystal structure mediates mode of cell death in TiO2 nanotoxicity. J. Nanopart. Res. 2009, 11, 1361–1374. [Google Scholar] [CrossRef]
  62. Thevenot, P.; Cho, J.; Wavhal, D.; Timmons, R.B.; Tang, L. Surface chemistry influences cancer killing effect of TiO2 nanoparticles. Nanomed: Nanotechnol. Biol. Med. 2008, 4, 226–236. [Google Scholar] [CrossRef]
  63. Sweeney, S.; Berhanu, D.; Ruenraroengsak, P.; Thorley, A.J.; Valsami-Jones, E.; Tetley, T.D. Nano-titanium dioxide bioreactivity with human alveolar type-I-like epithelial cells: Investigating crystalline phase as a critical determinant. Nanotoxicology 2014, 19, 1–11. [Google Scholar] [CrossRef]
  64. Noël, A.; Maghni, K.; Cloutier, Y.; Dion, C.; Wilkinson, K.J.; Hallé, S.; Tardif, R.; Truchon, G. Effects of inhaled nano-TiO2 aerosols showing two distinct agglomeration states on rat lungs. Toxicol. Lett. 2012, 214, 109–119. [Google Scholar] [CrossRef] [PubMed]
  65. Noël, A.; Cloutier, Y.; Wilkinson, K.J.; Dion, C.; Hallé, S.; Maghni, K.; Tardif, R.; Truchon, G. Generating nano-aerosols from TiO2 (5 nm) nanoparticles showing different agglomeration states. Application to toxicological studies. J. Occup. Environ. Hyg. 2013, 10, 86–96. [Google Scholar] [CrossRef] [PubMed]
  66. Noël, A.; Charbonneau, M.; Cloutier, Y.; Tardif, R.; Truchon, G. Rat pulmonary responses to inhaled nano-TiO2: Effect of primary particle size and agglomeration state. Part. Fibre Toxicol. 2013, 10, 48. [Google Scholar] [CrossRef] [PubMed]
  67. Ferin, J.; Oberdorster, G. Biological effects and toxicity assessment of titanium dioxides: Anatase and rutile. Am. Ind. Hyg. Assoc. J. 1985, 46, 69–72. [Google Scholar] [PubMed]
  68. Jiang, J.; Oberdorster, G.; Elder, A.; Gelein, R.; Mercer, P.; Biswas, P. Does nanoparticle activity depend upon size and crystal phase? Nanotoxicology 2008, 2, 33–42. [Google Scholar] [CrossRef] [PubMed]
  69. Pott, F.; Althoff, G.H.; Roller, M.; Hoehr, D.; Friemann, J.L. High acute toxicity of hydrophobic ultrafine titanium dioxide in an intratracheal study with several dusts in rats [A]. In Relationships between Respiratory Disease and Exposure to Air Pollution [C]; ILSI Press: Washington, DC, USA, 1998; pp. 270–277. [Google Scholar]
  70. Wang, J.; Fan, Y.; Gao, Y.; Hu, Q.; Wang, T. TiO2 nanoparticles translocation and potential toxicological effect in rats after intraarticular injection. Biomaterials 2009, 30, 4590–4600. [Google Scholar] [CrossRef] [PubMed]
  71. Li, B.; Ze, Y.; Sun, Q.; Zhang, T.; Sang, X.; Cui, Y.; Wang, X.; Gui, S.; Tan, D.; Zhu, M.; et al. Molecular mechanisms of nanosized titanium dioxide-induced pulmonary injury in mice. PLoS One 2013, 8, e55563. [Google Scholar] [CrossRef] [PubMed]
  72. Bhattacharya, K.; Davoren, M.; Boertz, J.; Schins, R.P.; Hoffmann, E.; Dopp, E. Titanium dioxide nanoparticles induce oxidative stress and DNA-adduct formation but not DNA-breakage in human lung cells. Part. Fibre Toxicol. 2009, 6, 17. [Google Scholar] [CrossRef] [PubMed]
  73. Tang, Y.; Wang, F.; Jin, C.; Liang, H.; Zhong, X.; Yang, Y. Mitochondrial injury induced by nanosized titanium dioxide in A549 cells and rats. Environ. Toxicol. Pharmacol. 2013, 36, 66–72. [Google Scholar] [CrossRef] [PubMed]
  74. Singh, S.; Shi, T.; Duffin, R.; Albrecht, C.; Vanberlo, D.; Hohr, D.; Fubini, B.; Martra, G.; Fenoglio, I.; Borm, P. Endocytosis, oxidative stress and IL-8 expression in human lung epithelial cells upon treatment with fine and ultrafine TiO2: Role of the specific surface area and of surface methylation of the particles. Toxicol. Appl. Pharmacol. 2007, 222, 141–151. [Google Scholar] [CrossRef] [PubMed]
  75. Sun, Q.; Tan, D.; Zhou, Q.; Liu, X.; Cheng, Z.; Liu, G.; Zhu, M.; Sang, X.; Gui, S.; Cheng, J.; et al. Oxidative damage of lung and its protective mechanism in mice caused by long-term exposure to titanium dioxide nanoparticles. J. Biomed. Mater. Res. A 2012, 100A, 2554–2562. [Google Scholar] [CrossRef] [PubMed]
  76. Yazdi, A.S.; Guarda, G.; Riteau, N.; Drexler, S.K.; Tardivel, A.; Couillin, I.; Tschopp, J. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β. Proc. Natl. Acad. Sci. USA 2010, 107, 19449–19454. [Google Scholar] [CrossRef] [PubMed]
  77. Xia, T.; Kovochich, M.; Brant, J.; Hotze, M.; Sempf, J.; Oberley, T.; Sioutas, C.; Yeh, J.I.; Wiesner, M.R.; Nel, A.E. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006, 6, 1794–1807. [Google Scholar] [CrossRef] [PubMed]
  78. Scherbart, A.M.; Langer, J.; Bushmelev, A.; van Berlo, D.; Haberzettl, P.; van Schooten, F.J.; Schmidt, A.M.; Rose, C.R.; Schins, R.P.; Albrecht, C. Contrasting macrophage activation by fine and ultrafine titanium dioxide particles is associated with different uptake mechanisms. Part. Fibre Toxicol. 2011, 8, 31. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Wang, J.; Fan, Y. Lung Injury Induced by TiO2 Nanoparticles Depends on Their Structural Features: Size, Shape, Crystal Phases, and Surface Coating. Int. J. Mol. Sci. 2014, 15, 22258-22278. https://doi.org/10.3390/ijms151222258

AMA Style

Wang J, Fan Y. Lung Injury Induced by TiO2 Nanoparticles Depends on Their Structural Features: Size, Shape, Crystal Phases, and Surface Coating. International Journal of Molecular Sciences. 2014; 15(12):22258-22278. https://doi.org/10.3390/ijms151222258

Chicago/Turabian Style

Wang, Jiangxue, and Yubo Fan. 2014. "Lung Injury Induced by TiO2 Nanoparticles Depends on Their Structural Features: Size, Shape, Crystal Phases, and Surface Coating" International Journal of Molecular Sciences 15, no. 12: 22258-22278. https://doi.org/10.3390/ijms151222258

Article Metrics

Back to TopTop